(Australia-NewsWire.Com, February 20, 2018 ) According to the report Epigenetics, published by Market Data Forecast, the Asia Pacific market is projected to reach USD 224 million by 2021, at a CAGR of 16% from 2016 to 2021. As humans grow and develop, depending on the interactions they made, circumstances they live in some genes become dormant or active to make who they are. Epigenetics is the study of these changes and factors that influence them. These changes decide how a cell should act and it may cause diseases sometimes like cancer. These epigenomes are sometimes inherited by their offspring.
Asia Pacific Epigenetics: Drivers & Restraints Epigenetics market in this region is driven by factors like growing incidence of cancer, rising R&D investments and growing frequency of research activities among others. However, the market is constrained owing to factors such as high price of instruments and lack of trained professionals among others.
Asia Pacific Epigenetics: Segmentation By Product • Introduction • Enzymes o DNA-Modifying Enzymes o Protein-Modifying Enzymes o RNA-Modifying Enzymes • Instruments & Consumables o Mass Spectrometers o Next-Generation Sequencers o QPCR o Sonicators o Others • KITS o Bisulfite Conversion KITS o Chip-Sequence KITS o RNA Sequencing KITS o Whole-Genome Amplification KITS o 5-HMC and 5-MC Analysis KITS o Others • Reagents o Antibodies o Buffers o Histones o Magnetic Beads o Primers o Others By Research Area • Introduction • Developmental Biology • Oncology • Drug Delivery By Geography • Asia-Pacific o China o India o Japan o Australia o South Korea
Asia Pacific Epigenetics: Overview Factors such as rising R&D investments and growing frequency of research activities are affecting the growth of this market positively. However, other factors such as lack of trained professionals and high cost of instruments are expected to constrain the growth of this market. In this market, oncology segment has the largest share, while drug discovery segment is expected to grow at the fastest rate. Globally, Asia Pacific region is expected to grow at the fastest rate.
Asia Pacific Epigenetics: Key Players Some of the major companies dominating Asia Pacific Epigenetics Market are Active Motif, Diagenode, Inc. Abcam plc., Thermo Fisher Scientific, Inc., Illumina, Inc., New England Biolabs, Inc., Sigma-Aldrich Corporation, QIAGEN N.V., Merck & Co. and Zymo Research Corporation among others.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.